Primatope Therapeutics primatope.com


Public list: BIO 2016 (619) Pharma Startups (4732)

Primatope Therapeutics has developed an antibody therapeutics discovery & development platform which enables the rapid translation of best-in-class monoclonal antibodies form the discovery to human clinical proof-of-concept. The company's lead product, 2C10, is a non-depleting, non-activating high affinity antagonist monoclonal antibody to CD40, a well-validated costimulatory target which plays a key role in immune tolerance. Efficacy of 2C10 mAb has been established in a number of different non...Show all

Primatope Therapeutics has developed an antibody therapeutics discovery & development platform which enables the rapid translation of best-in-class monoclonal antibodies form the discovery to human clinical proof-of-concept. The company's lead produc...Show all

Company (Alive / Active)

Phone: 617-244-3885

Fax:

508 Dudley Road
Suite 400
Newton Center, 02459
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Primatope Therapeutics $0.4M Dec 3, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Primatope Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Humanized anti-cd40 antibodies and methods of administering thereof Dec 01, 2017 May 22, 2018 Patent